Printer Friendly
The Free Library
14,670,911 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Catheters Set to Play an Expanding Role in Interventional Cardiology; New Survey by Greystone Associates Examines Therapeutic and Business Factors.


AMHERST, N.H. -- For millions of patients diagnosed with cardiovascular disease Cardiovascular disease
Disease that affects the heart and blood vessels.

Mentioned in: Lipoproteins Test

cardiovascular disease 
, interventional cardiology interventional cardiology Cardiology The subspecialty of cardiology dedicated to the diagnosis, medical and mechanical therapy, pre- and post-procedure management of adult patients with acute and chronic forms of cardiovascular disease amenable to catheter-based  is the last hope for alleviating symptoms and improving quality-of-life. The prevalence of CHD CHD coronary heart disease.

ChD
abbr.
Latin Chirurgiae Doctor (Doctor of Surgery)


CHD,
n.pr See disease, coronary heart.


CHD

canine hip dysplasia.
 and related conditions has and continues to be a significant public health issue. The number of interventional procedures performed in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  has steadily increased over the past 10 years and will continue to grow at a healthy rate.

Cardiovascular catheterization catheterization

Threading of a flexible tube (catheter) through a channel in the body to inject drugs or a contrast medium, measure and record flow and pressures, inspect structures, take samples, diagnose disorders, or clear blockages.
 is well-positioned to address this significant and expanding healthcare market need. Improvements in catheter designs and materials of construction have reduced the risks of complications and opened up new therapeutic applications, such as peripheral arterial and vascular stenting. While the value of these procedures relative to alternative treatments is still being debated, the ability of interventional cardiologists to address a growing list of cardiovascular conditions via catheterization is becoming well-established.

"The impact of interventional cardiology has increased dramatically in the last decade," explains George Perros, Greystone Associates Managing Director. "Growth in this sector will be driven by an aging patient population, further improvements in catheter designs, and by improved outcomes resulting from drug-device combination medical products."

The survey's findings are contained in a new publication. Cardiovascular Catheterization: North American North American

named after North America.


North American blastomycosis
see North American blastomycosis.

North American cattle tick
see boophilusannulatus.
 Markets and Prospects is a comprehensive report researched and written by Greystone Associates. The report contains a detailed assessment of catheter technology and products, profiles of market participants, industry data and forecasts, and detailed analysis of regulatory and market factors. Organized and written to be of maximum value to medical market professionals, device developers, technology providers, and market segment stakeholders, the report provides a detailed assessment of the growing potential for catheters in interventional cardiovascular diagnostics and therapeutics.

More information is available at www.greystoneassociates.org

About Greystone

Greystone Associates is a medical and healthcare technology consulting firm Noun 1. consulting firm - a firm of experts providing professional advice to an organization for a fee
consulting company

business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a
 providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 3, 2005
Words:310
Previous Article:Dallas-Fort Worth Film Critics Announce Best Film Awards of 2004 Tonight at the Angelika Film Center - Dallas.
Next Article:Applied Biosystems Releases Expanded Version of the PANTHER Protein Classification System Database.



Related Articles
Premier Signs Two-Year Agreement With Cook Incorporated for Diagnostic and Interventional Radiology Products.
POSITIVE DATA ON SCHERING'S AD5FGF-4 FOR CHRONIC STABLE ANGINA.
Are Coated Devices the Future of Interventional Therapeutics? New Survey by Greystone Associates Examines Potential for Drug-Coated Devices.
St. Jude Medical Announces European Launch of Three Cardiology Products at EuroPCR 2005 Meeting in Paris.
Therapeutic Angiogenesis - Is It the Future of Cardiovascular Medicine?; New Survey by Greystone Associates Examines the Impact of Emerging Therapies.
New Generation of Diagnostic Imaging Agents Raising Expectations and Expanding Applications; Greystone Associates Analyzes Trend toward Metabolic and...
Evolving Embolic Protection Devices Providing Practitioners with More Options.
Onset Medical Receives FDA Clearance to Market SoloPath(TM) Percutaneous Transseptal Access Catheter.
FIRST HEART ATTACK PATIENT ENROLLED IN RAPID MI-ICE STUDY.
Despite Limitations, the Lure of Transdermal Skin Patches Remains Strong.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles